Literature DB >> 22349487

Glomerular hyperfiltration: definitions, mechanisms and clinical implications.

Imed Helal1, Godela M Fick-Brosnahan, Berenice Reed-Gitomer, Robert W Schrier.   

Abstract

Glomerular hyperfiltration is a phenomenon that can occur in various clinical conditions including kidney disease. No single definition of glomerular hyperfiltration has been agreed upon, and the pathophysiological mechanisms, which are likely to vary with the underlying disease, are not well explored. Glomerular hyperfiltration can be caused by afferent arteriolar vasodilation as seen in patients with diabetes or after a high-protein meal, and/or by efferent arteriolar vasoconstriction owing to activation of the renin-angiotensin-aldosterone system, thus leading to glomerular hypertension. Glomerular hypertrophy and increased glomerular pressure might be both a cause and a consequence of renal injury; understanding the renal adaptations to injury is therefore important to prevent further damage. In this Review, we discuss the current concepts of glomerular hyperfiltration and the renal hemodynamic changes associated with this condition. A physiological state of glomerular hyperfiltration occurs during pregnancy and after consumption of high-protein meals. The various diseases that have been associated with glomerular hyperfiltration, either per nephron or per total kidney, include diabetes mellitus, polycystic kidney disease, secondary focal segmental glomerulosclerosis caused by a reduction in renal mass, sickle cell anemia, high altitude renal syndrome and obesity. A better understanding of the mechanisms involved in glomerular hyperfiltration could enable the development of new strategies to prevent progression of kidney disease.

Entities:  

Mesh:

Year:  2012        PMID: 22349487     DOI: 10.1038/nrneph.2012.19

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  95 in total

1.  Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.

Authors:  Grégoire Wuerzner; Menno Pruijm; Marc Maillard; Pascal Bovet; Claude Renaud; Michel Burnier; Murielle Bochud
Journal:  Am J Kidney Dis       Date:  2010-06-09       Impact factor: 8.860

2.  Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome.

Authors:  J C Jennette; L Charles; W Grubb
Journal:  Am J Kidney Dis       Date:  1987-12       Impact factor: 8.860

3.  Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy.

Authors:  M Praga; E Hernández; J C Herrero; E Morales; Y Revilla; R Díaz-González; J L Rodicio
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

4.  Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients.

Authors:  Frank Pistrosch; Kay Herbrig; Beate Kindel; Jens Passauer; Sabine Fischer; Peter Gross
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

5.  Glomerular hyperfiltration and serum beta 2-microglobulin used as early markers in diagnosis of autosomal dominant polycystic kidney disease.

Authors:  D Dimitrakov; E Kumchev; E Lyutakova; L Grigorov
Journal:  Folia Med (Plovdiv)       Date:  1993

Review 6.  Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.

Authors:  Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 10.121

7.  Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats.

Authors:  Gerd Luippold; Martina Beilharz; Bernd Mühlbauer
Journal:  Nephrol Dial Transplant       Date:  2004-02       Impact factor: 5.992

Review 8.  Current concepts of renal hemodynamics in diabetes.

Authors:  S Anderson; J P Vora
Journal:  J Diabetes Complications       Date:  1995 Oct-Dec       Impact factor: 2.852

Review 9.  Glomerular hypertension: cause and consequence of renal injury.

Authors:  J R Neuringer; B M Brenner
Journal:  J Hypertens Suppl       Date:  1992-12

10.  Rate of functional deterioration in polycystic kidney disease.

Authors:  K A Franz; F C Reubi
Journal:  Kidney Int       Date:  1983-03       Impact factor: 10.612

View more
  206 in total

1.  Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway.

Authors:  Wei Cao; Jie Xu; Zhan Mei Zhou; Guo Bao Wang; Fan Fan Hou; Jing Nie
Journal:  Antioxid Redox Signal       Date:  2012-07-30       Impact factor: 8.401

2.  Improvement of Kidney Function Following Bariatric Surgery: Hope or Illusion?

Authors:  G Favre; A S Schneck; R Anty; V L M Esnault; A Iannelli
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

Review 3.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 4.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

Review 5.  Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 10.121

Review 6.  Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease?

Authors:  Nia S Mitchell; Julia J Scialla; William S Yancy
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

7.  Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Ashley C Johnson; Lateia Taylor; Cassandra Stubbs; Alyssa Nichols; Denise C Cornelius; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2020-02-18

8.  Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch.

Authors:  Frank Weidemann; Johannes Krämer; Thomas Duning; Malte Lenders; Sima Canaan-Kühl; Alice Krebs; Hans Guerrero González; Claudia Sommer; Nurcan Üçeyler; Markus Niemann; Stefan Störk; Michael Schelleckes; Stefanie Reiermann; Jörg Stypmann; Stefan-Martin Brand; Christoph Wanner; Eva Brand
Journal:  J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 10.121

Review 9.  Early detection of diabetic kidney disease: Present limitations and future perspectives.

Authors:  Chih-Hung Lin; Yi-Cheng Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2016-07-25

10.  Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.

Authors:  R Malhotra; K L Cavanaugh; W J Blot; T A Ikizler; L Lipworth; E K Kabagambe
Journal:  Nutr Metab Cardiovasc Dis       Date:  2016-07-21       Impact factor: 4.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.